InvestorsHub Logo

EM

Followers 7
Posts 879
Boards Moderated 0
Alias Born 09/21/2016

EM

Re: bladerunner1717 post# 1210

Saturday, 01/07/2017 3:36:26 PM

Saturday, January 07, 2017 3:36:26 PM

Post# of 1394
Yes, both are multimillion market per "global data".

Initiation of Phase II dose optimization study in high & very high risk MDS (1H 2017).

"Agree to share cost of Phase II study to explore optimal dosing regimen of Pracinostat + azacitidine in high and very high risk MDS".

Anyway, royalties will depend on revenues and if 401 will show great data results on Q1, we can see some interest from BP as well.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MEIP News